MeSH tree: C14.280.238.100
The development of novel therapeutics offers great hope for the fight against widespread diseases such as cancer, but they can impair the cardiovascular system, so development often fails early on.
May 5, 2025
0
19
Energy drinks are a multibillion-dollar industry and are the most consumed supplement not under the control of the Food and Drug Administration other than multivitamins. It's a bit like the "Wild West" in the sense that energy ...
May 5, 2025
0
117
An Israeli study has identified TRIM63 as a significant genetic contributor to hypertrophic cardiomyopathy (HCM)—the most common hereditary heart disease worldwide. The findings, published in Circulation: Genomic and Precision ...
Apr 23, 2025
0
21
Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify patients with the condition ...
Apr 22, 2025
0
25
It's the most wonderful time of the year to be a basketball fan. And whether you're enjoying the memory of your alma mater's winning buzzer-beater in the NCAA tournament or hoping to see your favorite pro posterize an opponent ...
Apr 10, 2025
0
14
Two common and potentially deadly heart diseases can be caused by mutations in the same gene. Surprisingly, though, these two conditions are each associated with very different clinical symptoms. Using engineered heart tissue, ...
Apr 1, 2025
0
23
Affecting 1 in 500 people, hypertrophic cardiomyopathy is a condition in which the walls of the left ventricle, the heart's main pumping chamber, become abnormally thick. "HCM is one of the primary causes of sudden death ...
Mar 20, 2025
0
14
It's often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in one in 500 people.
Feb 27, 2025
0
16
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL researchers.
Jan 8, 2025
0
23
Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe hypertrophic cardiomyopathy (HCM) caused by pathogenic variants in the RAS/MAPK pathway, according to ...
Jan 8, 2025
0
39
